335 related articles for article (PubMed ID: 26643367)
1. Erythropoietin alleviates hepatic insulin resistance via PPARγ-dependent AKT activation.
Ge Z; Zhang P; Hong T; Tang S; Meng R; Bi Y; Zhu D
Sci Rep; 2015 Dec; 5():17878. PubMed ID: 26643367
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells.
Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D
Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239
[TBL] [Abstract][Full Text] [Related]
4. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice.
Meng R; Zhu D; Bi Y; Yang D; Wang Y
PLoS One; 2013; 8(1):e53557. PubMed ID: 23326455
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin improves insulin resistance via the regulation of its receptor-mediated signaling pathways in 3T3L1 adipocytes.
Pan Y; Shu JL; Gu HF; Zhou DC; Liu XL; Qiao QY; Fu SK; Gao FH; Jin HM
Mol Cell Endocrinol; 2013 Mar; 367(1-2):116-23. PubMed ID: 23313788
[TBL] [Abstract][Full Text] [Related]
7. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway.
Gandhi GR; Jothi G; Antony PJ; Balakrishna K; Paulraj MG; Ignacimuthu S; Stalin A; Al-Dhabi NA
Eur J Pharmacol; 2014 Dec; 745():201-16. PubMed ID: 25445038
[TBL] [Abstract][Full Text] [Related]
8. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS
J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940
[TBL] [Abstract][Full Text] [Related]
9. Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway.
Yan J; Wang C; Jin Y; Meng Q; Liu Q; Liu Z; Liu K; Sun H
Pharmacol Res; 2018 Apr; 130():466-480. PubMed ID: 29284152
[TBL] [Abstract][Full Text] [Related]
10. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
[TBL] [Abstract][Full Text] [Related]
11. Calcium Supplementation Enhanced Adipogenesis and Improved Glucose Homeostasis Through Activation of Camkii and PI3K/Akt Signaling Pathway in Porcine Bone Marrow Mesenchymal Stem Cells (pBMSCs) and Mice Fed High Fat Diet (HFD).
Zhang F; Ye J; Meng Y; Ai W; Su H; Zheng J; Liu F; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
Cell Physiol Biochem; 2018; 51(1):154-172. PubMed ID: 30439703
[TBL] [Abstract][Full Text] [Related]
12. PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders.
Wang L; Teng R; Di L; Rogers H; Wu H; Kopp JB; Noguchi CT
Diabetes; 2013 Dec; 62(12):4122-31. PubMed ID: 23990359
[TBL] [Abstract][Full Text] [Related]
13. Taurine improves low-level inorganic arsenic-induced insulin resistance by activating PPARγ-mTORC2 signalling and inhibiting hepatic autophagy.
Gao N; Yao X; Jiang L; Yang L; Qiu T; Wang Z; Pei P; Yang G; Liu X; Sun X
J Cell Physiol; 2019 Apr; 234(4):5143-5152. PubMed ID: 30362509
[TBL] [Abstract][Full Text] [Related]
14. Insulin sensitization via partial agonism of PPARγ and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in type 2 diabetic rats.
Gandhi GR; Stalin A; Balakrishna K; Ignacimuthu S; Paulraj MG; Vishal R
Biochim Biophys Acta; 2013 Jan; 1830(1):2243-55. PubMed ID: 23104384
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells.
Kumar SM; Yu H; Fong D; Acs G; Xu X
Melanoma Res; 2006 Aug; 16(4):275-83. PubMed ID: 16845323
[TBL] [Abstract][Full Text] [Related]
16. PGBR extract ameliorates TNF-α induced insulin resistance in hepatocytes.
Chen FC; Shen KP; Chen JB; Lin HL; Hao CL; Yen HW; Shaw SY
Kaohsiung J Med Sci; 2018 Jan; 34(1):14-21. PubMed ID: 29310812
[TBL] [Abstract][Full Text] [Related]
17. Toona Sinensis ameliorates insulin resistance via AMPK and PPARγ pathways.
Liu HW; Huang WC; Yu WJ; Chang SJ
Food Funct; 2015 Jun; 6(6):1855-64. PubMed ID: 25940430
[TBL] [Abstract][Full Text] [Related]
18. Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells.
Cordero-Herrera I; Martín MÁ; Goya L; Ramos S
Food Chem Toxicol; 2014 Feb; 64():10-9. PubMed ID: 24262486
[TBL] [Abstract][Full Text] [Related]
19. Casein glycomacropeptide-derived peptide IPPKKNQDKTE ameliorates high glucose-induced insulin resistance in HepG2 cells via activation of AMPK signaling.
Song JJ; Wang Q; Du M; Li TG; Chen B; Mao XY
Mol Nutr Food Res; 2017 Feb; 61(2):. PubMed ID: 27506476
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
